{"id":"W2980072580","doi":"10.4081/oncol.2019.425","title":"Efficacy and safety profiles of programmed cell death-1/programmed cell death ligand-1 inhibitors in the treatment of triple-negative breast cancer: A comprehensive systematic review","year":2019,"lang":"en","type":"article","venue":"Oncology Reviews","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Triple-negative breast cancer; Neutropenia; Oncology; Internal medicine; Adverse effect; PD-L1; Breast cancer; Cancer; Immunotherapy; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009367795,0.0003541864,0.002897869,0.00009810281,0.00003978069,0.000007018598,0.0001677761,0.0001560636,0.00004591062],"category_scores_gemma":[0.00004897193,0.0001858022,0.0003857515,0.0004937272,0.0001756616,0.00003932533,0.00002373606,0.0001642316,0.000009407942],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000351961,"about_ca_system_score_gemma":0.000308411,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000494402,"about_ca_topic_score_gemma":0.00009911095,"domain_scores_codex":[0.9966153,0.0009135808,0.001556954,0.0003768512,0.0002220445,0.0003152677],"domain_scores_gemma":[0.9975036,0.0005050126,0.001204063,0.0005441831,0.0001618219,0.00008136031],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.008585488,0.008384204,0.03064223,0.7109355,0.0009872844,0.00005894782,0.008443289,4.482158e-7,0.01465595,0.00003345412,0.001126049,0.2161472],"study_design_scores_gemma":[0.09453541,0.03796846,0.06560579,0.5037534,0.01302266,0.0009336012,0.004194552,0.00004573025,0.02323462,0.00002280675,0.2552194,0.001463611],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.385322,0.5855195,0.000001237486,0.001086846,0.0001602449,0.02721834,0.00004595922,0.00001521936,0.0006306245],"genre_scores_gemma":[0.1969947,0.7981249,0.0006038507,0.0007997663,0.0000584325,0.002962282,0.00004508366,0.00003042368,0.0003805318],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2540934,"threshold_uncertainty_score":0.7576794,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03448186857445616,"score_gpt":0.3339692933621759,"score_spread":0.2994874247877197,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}